All posts by: Michael Zand

About Michael Zand

Newly approved CAR-T therapy could mark breakthrough in cancer treatments – Genetic Literacy Project

Continue reading

2017-08-29 NEWS

Genetic Literacy Project

Newly approved CART therapy could mark breakthrough in cancer treatments
Genetic Literacy Project
Carl H. June, MD, is a professor of immunology at the University of Pennsylvania Perelman School of Medicine. He developed what is known as Chimeric Antigen Receptor Tcell therapy (CAR-T) which is an engineered version of a patient’s Tcells to …

Continue reading

2017-08-29 NEWS

Medical Xpress

Researchers discover new immunotherapy combination effective at killing cancer cells
Medical Xpress
Immunotherapy is an emerging field in the global fight against cancer, even though scientists and clinicians have been working for decades to find ways to help the body’s immune system detect and attack cancerous cells. Doug Mahoney’s lab at the …
New treatment eradicates cancer cells in Glasgow University studyBBC News
Glasgow university scientists find new method of killing cancer cellsThe Times
Anti-cancer breakthrough CICD can eradicate tumours, researchers saySky News

all 15 news articles »

Continue reading

2017-08-29 NEWS

Medical Xpress

Researchers discover new immunotherapy combination effective at killing cancer cells
Medical Xpress
Immunotherapy is an emerging field in the global fight against cancer, even though scientists and clinicians have been working for decades to find ways to help the body’s immune system detect and attack cancerous cells. Doug Mahoney’s lab at the …
New treatment eradicates cancer cells in Glasgow University studyBBC News
Glasgow university scientists find new method of killing cancer cellsThe Times
Anti-cancer breakthrough CICD can eradicate tumours, researchers saySky News

all 15 news articles »

Continue reading

2017-08-29 NEWS

CSL Behring to acquire stem cell therapy biotech firm
The Pharma Letter (registration)
Blood products and vaccines specialist CSL Behring, a subsidiary of Australia’s CSL Limited (ASX: CSL), has agreed to acquire Calimmune, a US biotechnology company focused on the development of ex vivo hematopoietic stem cell (HSC) gene therapy …

and more »

Continue reading

2017-08-29 NEWS

Technology Networks

Stem Cell Treatment Helps Puppies With Spina Bifida
Technology Networks
A pair of English bulldog puppies are the first patients to be successfully treated with a unique therapy — a combination of surgery and stem cells — developed at the University of California, Davis, to help preserve lower-limb function in children

Continue reading

2017-08-29 NEWS

Technology Networks

Stem Cell Treatment Helps Puppies With Spina Bifida
Technology Networks
A pair of English bulldog puppies are the first patients to be successfully treated with a unique therapy — a combination of surgery and stem cells — developed at the University of California, Davis, to help preserve lower-limb function in children